CDIO
Cardio DiagnosticsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
CDIO Profile
Cardio Diagnostics Holdings,Inc.
A biotechnology company that develops cloud-based cardiac monitoring system for cardiovascular disease prevention
Biological Technology
09/06/2019
01/14/2022
NASDAQ Stock Exchange
13
12-31
Common stock
311 West Superior Street, Suite 444, Chicago, IL 60654
--
Cardio Diagnostics Holdings, Inc., was incorporated under the laws of the State of Delaware on September 6, 2019. Cardio Diagnostics is a biotechnology company dedicated to making the prevention and early detection of cardiovascular disease more accessible, personalized and precise. Cardio was established to further develop and commercialize a proprietary artificial intelligence-driven integrated genetic-epigenetic EngineTM for cardiovascular disease, becoming one of the leading medical technology companies capable of improving the prevention, early detection and adjuvant treatment of cardiovascular disease.
